Comerica Bank
ARIA

Comerica Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Comerica Bank’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-17,668
Closed -$142K – 2269
2014
Q1 		$142K Buy
17,668
+212
+1% +$1.65K ﹤0.01% 2193
2013
Q4 		$119K Sell
17,456
-20,177
-54% -$109K ﹤0.01% 2186
2013
Q3 		$693K Sell
37,633
-1,207
-3% -$23.4K ﹤0.01% 1846
2013
Q2 		$679K Buy
+38,840
New +$689K 0.01% 1596

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Comerica Bank's ARIA Position: Q2 2014 in Review

Comerica Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2014, closing a stake of 17,668 shares — an estimated $142K sold.

Comerica Bank first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $693K in Q3 2013. 169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.

  • Comerica Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Comerica Bank sold 17,668 Ariad Pharmaceuticals Inc shares in Q2 2014, an estimated $142K.
  • Comerica Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Comerica Bank's Ariad Pharmaceuticals Inc position peaked at $693K in Q3 2013.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.

Based on Comerica Bank's 13F filing for Q2 2014, filed 12 Aug 2014.